Skip to content
Home/Companies/Biotech/Biophta
BI

Biophta

Biotech·France·Active·2yr hold

Biophta is a biotechnology company, headquartered in France.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Biophta?

Biophta is currently owned by Elaia Partners through DTS3 (2024 vintage), since 2024. Across its history, Biophta has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Elaia Partners
Most recent investor
Elaia Partners
DTS3 · 2024 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorBiotechnology

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Go Capital and Elaia Partners since 2024.
Co-invest · 2 holders · 2024 · present
Go Capital
Go CapitalActive
2024 · present · GOCA3 · 2023 · VC
MOIC
–
Elaia Partners
Elaia PartnersActive
2024 · present · DTS3 · 2024 · VC
MOIC
–

More from DTS3

Other portfolio companies in the same fund.

GetVocal AI
Active
Data & AnalyticsFrance· 2025
Mimic Robotics
Active
IndustrialsUS· 2025
Proxima Fusion
Active
EnergyGermany· 2025
Streambased
Active
Data & AnalyticsUK· 2025
dottxt
Active
Data & AnalyticsFrance· 2024
Dunia
Active
ClimateTechGermany· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings